Bitter Pills:Medicines & The Third World Poor | Page 240
in the Therapeutic Index should be corrected, including incorporation of side-effects and contraindications. As soon as this has been printed I will send you a copy." (Dr. T. Vossenaar, Organon,
personal communication, 23 April 1982.)
71
ABP1, 1979, op.cit., p.1013.
72
British National Formulary 1981, op.cit., p.201.
73
P. W. Cunliffe, Chairman Pharmaceuticals Division, ICI, personal communication,
11 February 1982.
74
Dr. D. M. Burlcy, Ciba-Geigy, personal communication, 1 April 1982.
75
-
Ciba-Geigy statement on aminophenazone (amidopyrine) S O ? / P No. 666, lOFebruary
1982, p.14.
Dr. D. M. Burley, Ciba-Geigy, personal communication, 4 February 1982.
Silverman, Lee and Lydecker, op.cit., p.60.
76
-
Dr. Burley, personal communication 4 February 1982.
Dr. G. R. Venning, "Validity of anecdotal report sol'suspected adverse drug read ions:
the problem of false alarms", British Medical Journal, Volume 284, 23 January 1982,.
p.25O.
77
-
The withdrawal of amidopyrine was recommended "because of its ability to form
carcinogenic nitrosamines either spontaneously or by interaction with nitrites in food",
P. Epstein and J. S. Yudkin, letter to The Lancet, 13 August, 1978.
SCRIP No. 666, op.cit.
Burley, personal communication 4 February 1982, op.cit.
78
-
Ibid.
Brudon, op.cit., p.236.
79
J. S. Yudkin, letter to The Lancet, 14 November 1981, p.1114.
80
Entry for Cibalgin (with aminophenazone) MIMSMiddle East, Volume 11, Number 2,1980, p.57.
81
Brudon, op.cit., p.236.
82
Dr. Burley, personal communication, 4 February 1982.
83
-
84
The Lancet, 14 November 1981, op.cit.
85
Brudon, op.cit., p.236.
86
The Lancet, 14 November 1981, op. cit.
87
-
Ibid.
SCRIP No. 666, op. cit.
Ibid.
Personal communication from Stephen de Winter of Belbo Film Productions.
88
Dr. Burley, personal communication, 4 February 1982.
89
"Special Report", The Hindu, 6 January 1981.
90
Ibid.
91
92
The Lancet, 2 August 1980, op. cit.
Dr. Burley, Ciba-Geigy, personal communication, 12 March 1982. Ciba have stressed that
" It is not right to infer that amidopyrine has been dumped in the Third World. On the contrary
far more has been sold in the developed world ..." (Burley, personal communication, 4 February
1982, op. cit.)
C. M. Huguley, "Agranulocytosis induced bydipyrone, a hazardous antipyretic and analgesic",
JAMA 189; 1964, pp.938-941, quoted by J. S. Yudkin," The Economics of Pharmaceutical
Supply in Tanzania", International Journal of Health Services, Volume 10, Number 3, 1980,
pp.455-477.
93
233